Financial Analysis: Avant Diagnostics (AVDX) vs. Fly Leasing (FLY)

Avant Diagnostics (OTCMKTS:AVDX) and Fly Leasing (NYSE:FLY) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Risk & Volatility

Avant Diagnostics has a beta of 3.73, indicating that its stock price is 273% more volatile than the S&P 500. Comparatively, Fly Leasing has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500.


This table compares Avant Diagnostics and Fly Leasing’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Avant Diagnostics N/A N/A N/A
Fly Leasing 15.32% 11.41% 1.80%

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Avant Diagnostics and Fly Leasing, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avant Diagnostics 0 0 0 0 N/A
Fly Leasing 2 0 1 0 1.67

Fly Leasing has a consensus target price of $19.83, indicating a potential upside of 63.91%. Given Fly Leasing’s higher possible upside, analysts plainly believe Fly Leasing is more favorable than Avant Diagnostics.

Earnings & Valuation

This table compares Avant Diagnostics and Fly Leasing’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Avant Diagnostics $110,000.00 33.70 -$11.75 million N/A N/A
Fly Leasing $353.25 million 0.98 $2.59 million $0.09 134.44

Fly Leasing has higher revenue and earnings than Avant Diagnostics.

Institutional & Insider Ownership

0.0% of Avant Diagnostics shares are owned by institutional investors. Comparatively, 50.3% of Fly Leasing shares are owned by institutional investors. 38.0% of Avant Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.


Fly Leasing beats Avant Diagnostics on 8 of the 11 factors compared between the two stocks.

About Avant Diagnostics

Avant Diagnostics, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary diagnostic tests that provide information for physicians and patients in the areas of cancers. It offers OvaDx, a noninvasive proteomics diagnostic screening test for the early detection of ovarian cancer; and MSPrecise, a DNA sequencing assay for the identification of patients with relapsing-remitting multiple sclerosis at first clinical presentation. The company is based in Washington, District of Columbia.

About Fly Leasing

Fly Leasing Limited, through its subsidiaries, purchases and leases commercial aircrafts under multi-year contracts to various airlines worldwide. As of December 31, 2017, the company had a portfolio of 85 aircrafts, including 73 narrow-body passenger aircrafts and 12 wide-body passenger aircrafts. Fly Leasing Limited was founded in 2007 and is headquartered in Dún Laoghaire, Ireland.

Receive News & Ratings for Avant Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avant Diagnostics and related companies with's FREE daily email newsletter.

Leave a Reply